Insider trades

Atul Pande, Director of Immunovant IMVT, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $300K. The latest trade was on 06/26.

Atul Pande

Director
First filing
23/04/14
Trades
28 trades
Buys / sales
0 / 7
12-month net buying
−$300K
Last trade
06/26

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2606/261,500 sh$38.01$57,015−1.3%
Open-market sale10b5-1 plan06/1506/161,500 sh$34.02$51,030−1.3%
Open-market sale10b5-1 plan05/2005/206,000 sh$32.00$192,000−4.9%
Open-market sale10b5-1 plan24/12/0224/12/047,750 sh$28.54$221,185−8.2%
IMVT
Open-market sale10b5-1 plan23/12/0123/12/0512,350 sh3 trades$39.73avg.$490,667.5−12.9%